CONFIDENTIAL TREATMENT REQUESTEDConfidential Treatment Requested • May 9th, 2018 • Immunogen Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 9th, 2018 Company Industry JurisdictionThis Multi-Target Agreement (this “Agreement”) is made effective as of the date of the last signature below (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (“ImmunoGen”), with its principal place of business at 830 Winter Street, Waltham, Massachusetts 02451, and Eli Lilly and Company, an Indiana corporation (“Lilly”), with its principal place of business at Lilly Corporate Center, Indianapolis, Indiana 46285. ImmunoGen and Lilly are sometimes each hereinafter referred to individually as a “Party” and collectively as the “Parties.”
CONFIDENTIAL TREATMENT REQUESTED MULTI-TARGET AGREEMENTConfidential Treatment Requested • August 19th, 2015 • Immunogen Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 19th, 2015 Company Industry JurisdictionThis Multi-Target Agreement (this “Agreement”) is made effective as of the date of the last signature below (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (“ImmunoGen”), with its principal place of business at 830 Winter Street, Waltham, Massachusetts 02451, and Eli Lilly and Company, an Indiana corporation (“Lilly”), with its principal place of business at Lilly Corporate Center, Indianapolis, Indiana 46285. ImmunoGen and Lilly are sometimes each hereinafter referred to individually as a “Party” and collectively as the “Parties.”